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Abstract
Background: The zinc finger protein Sp2 (specificity protein 2) is a member of the glutamine-rich Sp family of transcription
factors. Despite its close similarity to Sp1, Sp3 and Sp4, Sp2 does not bind to DNA or activate transcription when expressed
in mammalian cell lines. The expression pattern and the biological relevance of Sp2 in the mouse are unknown.
Methodology/Principal Findings: Whole-mount in situ hybridization of mouse embryos between E7.5 and E9.5 revealed
abundant expression in most embryonic and extra-embryonic tissues. In order to unravel the biological relevance of Sp2, we
have targeted the Sp2 gene by a tri-loxP strategy. Constitutive Sp2null and conditional Sp2cko knockout alleles were
obtained by crossings with appropriate Cre recombinase expressing mice. Constitutive disruption of the mouse Sp2 gene
(Sp2null) resulted in severe growth retardation and lethality before E9.5. Mouse embryonic fibroblasts (MEFs) derived from
Sp2null embryos at E9.5 failed to grow. Cre-mediated ablation of Sp2 in Sp2cko/cko MEFs obtained from E13.5 strongly
impaired cell proliferation.
Conclusions/Significance: Our results demonstrate that Sp2 is essential for early mouse development and autonomous
proliferation of MEFs in culture. Comparison of the Sp2 knockout phenotype with the phenotypes of Sp1, Sp3 and Sp4
knockout strains shows that, despite their structural similarity and evolutionary relationship, all four glutamine-rich
members of the Sp family of transcription factors have distinct non-redundant functions in vivo.
Citation: Baur F, Nau K, Sadic D, Allweiss L, Elsa¨sser H-P, et al. (2010) Specificity Protein 2 (Sp2) Is Essential for Mouse Development and Autonomous Proliferation
of Mouse Embryonic Fibroblasts. PLoS ONE 5(3): e9587. doi:10.1371/journal.pone.0009587
Editor: Ferenc Mueller, University of Birmingham, United Kingdom
Received December 23, 2009; Accepted February 17, 2010; Published March 8, 2010
Copyright:  2010 Baur et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants of the Deutsche Forschungsgemeinschaft to GS (GRK767) and the Dutch Organisation for Scientific Research
(Nederlandse Organisatie voor Wetenschappelijk Onderzoek, NWO) to SP (DN 82-294). The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Suske@imt.uni-marburg.de
Introduction
Specificity proteins (Sps) are transcription factors that control
the expression of a variety of different genes including house
keeping, tissue-specific, development-specific and cell-cycle-regu-
lated genes (reviewed in [1–4]). Nine different Sp proteins,
designated Sp1 to Sp9, have been identified in mammals [4].
They share a highly conserved zinc finger DNA-binding domain
comprising three zinc fingers at the C-terminus (ZNF), the
adjacent Buttonhead-box (Btd-box: CXCPXC), and the N-
terminal Sp-box, a stretch of conserved amino acids (SPLAL-
LAATCSK/RIG/E) of unknown function. The Sp subclass
members Sp1, Sp2, Sp3 and Sp4 are further characterized by
N-terminal glutamine-rich domains, whereas Sp5 to Sp9 contain
proline, alanine or serine/threonine-rich domains [1,4]. Sp1 and
Sp3 are ubiquitously expressed, whereas Sp4 is most prominently
found in neuronal tissues [1–3]. Sp1, Sp3 and Sp4 recognize the
same promoter elements (GC- and GT-boxes) with similar
specificity and affinity [5].
Gene targeting experiments revealed that individual Sp family
members differ in their biological function, as they exhibit distinct
phenotypes. Sp1null embryos die around embryonic day (E) 10.5
[6]. Sp3null mice develop until the end of pregnancy but die
immediately after birth due to respiratory failure [7]. Sp3null
embryos suffer from a variety of defects including impaired skeletal
bone ossification, tooth development [7,8], cardiac development
[9], and placenta organisation [10]. Newborn Sp4-deficient mice
do not show obvious abnormalities [11,12]. However, two-thirds
of the mice die within the first month after birth for unknown
reasons. Surviving Sp4-deficient animals are growth-retarded
[11,12]. Furthermore, both the male and female Sp4 null mice
have problems in reproduction; males do not breed and females
are delayed in sexual maturation [11,12]. Finally, Sp4 is required
for specification of the cardiac conduction system [13,14].
Sp2 is the least characterized member of the glutamine-rich
subgroup of Sp factors. Originally, Sp2 was cloned by virtue of the
similarity of its zinc finger domain with the zinc finger region of Sp1
[15]. Despite this similarity, Sp2 overexpressed in insect or
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mammalian cells binds poorly to DNA, and has little or no capacity
to stimulate transcription from promoters that are activated by other
Sp family members [16]. Consistently, endogenous Sp2 DNA-
binding activity in nuclear extracts prepared from cells that express
abundant amounts of Sp2 was not observed ([16], and our own
unpublished results). Sp2 is associated with the nuclear matrix and
localizes predominantly within subnuclear foci that are distinct from
promyelocytic oncogenic domains [17]. However, the functional
significance of this observation remains unclear.
Towards understanding the physiological relevance of Sp2, we
targeted the Sp2 gene and generated Sp2 loss-of-function mutants.
Sp2null embryos survive until E9.5 of gestation. They are severely
retarded in growth and show a broad range of phenotypic
abnormalities. Mouse embryonic fibroblasts (MEFs) derived from
Sp2null embryos failed to grow indicating a cell-autonomous role of
Sp2 in the control of cellular proliferation. This suggestion was
corroborated by MEFs obtained from embryos carrying floxed
Sp2 alleles (Sp2cko/cko). Cre-mediated ablation of Sp2 in Sp2cko/cko
MEFs resulted in a strong decrease of proliferation. Collectively,
we conclude that Sp2 is required for early mouse development and
autonomous proliferation of MEFs in culture.
Results
Expression of Sp2 in the Mouse Embryo
We analyzed expression of the zinc-finger transcription factor
Sp2 at early embryonic stages by whole-mount in situ hybridization
on E7.5 to E9.5 mouse embryos (Figure 1). At Theiler stage TS10
(E7.5) Sp2 is similarly expressed in embryonic as well as in extra-
embryonic tissues. At TS11 and TS12 Sp2 expression is markedly
increased in the embryonic tissues especially in the headfold. At a
later stage (TS15) strong expression of Sp2 is observed throughout
the embryo with exception of the heart. Control hybridizations
with the heart-specific markers Nkx2-5 and GATA4 confirmed the
accessibility of the heart for hybridization probes (Figure 1).
Strongest expression at this stage occurs in the neural tissues, the
neuroepithelium surrounding the optical and otic vesicles, the first
branchial arch and the forelimb buds and the auditory pit
(Figure 1). Taken together, our in situ hybridization experiments
indicate abundant expression of Sp2 in most embryonic and extra-
embryonic tissues during development.
Targeting of the Mouse Sp2 Gene
To investigate the role of Sp2 in development we generated
Sp2 knockout mice by homologous recombination in embryonic
stem cells. The open reading frame of the Sp2 gene encodes a
polypeptide of 612 amino acids with a predicted molecular
weight of 65 kDa. The entire amino acid sequence of Sp2 is
encoded by seven exons. Concerned that the loss of Sp2 might
produce early lethality, we employed a tri-loxP strategy to
generate Sp2null mice and Sp2 floxed mice, which could be used
for conditional knockout experiments. Similar to strategies that
we used previously for targeting the Sp3 and Sp4 genes, we
Figure 1. Sp2 mRNA expression in mouse embryos. Whole-mount in situ hybridization on embryos at the indicated developmental Theiler
stages (E7.5-TS10, E7.75-TS11, E8.0-TS12 and E9.5-TS15) with the indicated probes (Sp2, Sp2 sense, Nkx-2.5 and GATA4). The two embryos at E9.5
(TS15) represent two independent in situ hybridization experiments with embryos obtained from different litters. Ac, amniotic cavity; Ba, first
branchial arch; Hf, headfold; Fg, foregut; H, heart; Lb, limb bud; Nt, neuronal tissue; Op, optic pit; Ot, otic vesicle; S, somites; Tc, telencephalon. The
white arrowheads denote the boundary between embryonic and extraembryonic tissue.
doi:10.1371/journal.pone.0009587.g001
Sp2 Knockout Mice
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targeted exon 3, a large exon that encodes for most of the N-
terminal part of Sp2 including the Sp-box and two glutamine-rich
regions (Figure 2A). As Sp2 mRNA is expressed in mouse ES cells
(data not shown) the targeting strategy allowed expression of a
lacZ-neo fusion gene under the control of the endogenous Sp2
promoter (Figure 2A). Southern blot (Figure 2B) and PCR
analyses (Figure 2C) revealed successful homologous recombina-
tion in 8 out of 80 ES cell clones analyzed.
Mice heterozygous for the targeted Sp2 allele (Sp2wt/lzn) were
obtained after injection of ES cells into blastocysts and
subsequent crossing of the chimeric animals with wild type
mice. Sp2wt/lzn mice are viable, reproduce normally and
display no obvious abnormalities. Whole-mount LacZ staining
on E12.5 embryos confirmed the notion that Sp2 is widely if not
ubiquitously expressed during development (Figure 3A). As we
expected that the insertion of the IRES-lacZ-neo cassette would
result in impaired Sp2 expression, we crossed Sp2wt/lzn mice to
homozygosity. Northern blot analyses revealed aberrant Sp2
mRNA expression (Figure 3B). The 7 kb transcript expressed
from the Sp2lzn allele represents an RNA species containing
exon 1 to 3 of the Sp2 gene fused to LacZ-neo sequences. RT-
PCR analysis revealed that regions downstream of exon 3 are
not expressed from the Sp2lzn allele (Figure 3C). The presence
of an mRNA species containing Sp2 coding sequences was
expected to result in expression of an N-terminal Sp2 fragment.
Immunoblot analysis revealed the absence of the full-length Sp2
protein; a truncated Sp2 N-terminal fragment, however, was not
detected (Figure 3D). Control experiments with recombinant
Sp2 fragments showed that our Sp2 antiserum can detect the N-
terminal part of Sp2 (data not shown). Likely, expression of the
Sp2 N-terminal domain in Sp2lzn/lzn mice is below the
detection limit.
Impaired Development of Targeted Sp2lzn/lzn Mice
Genotyping of 91 10-day-old pups from heterozygous Sp2wt/lzn
intercrosses revealed wild type and heterozygous animals at the
expected 1:2 ratio. Only one homozygous Sp2lzn/lzn mutant pup
was found. This pub died before genotyping was finished and
could not be examined. We then examined intercross embryos at
E9.5 through E18.5 (Table 1). Overall, Sp2lzn/lzn embryos at
E16.5 and E18.5 were smaller than their wild type and
heterozygous littermates. They were generally developmentally
retarded, albeit with considerable variation (Figure 4). Moreover,
many of the Sp2lzn/lzn embryos were already dead at these
developmental stages. In contrast, Sp2lzn/lzn embryos at E12.5
had a normal body size. However, they displayed hemorrhaging,
predominantly in the head area (Figure 4). At E9.5 Sp2lzn/lzn
embryos appeared apparently normal. Taken together the various
Figure 2. Targeting strategy for the mouse Sp2 gene. A) Schematic representation of the Sp2 protein structure, the wild type Sp2 allele, the
targeting vector and the targeted Sp2lzn allele. The Sp-box (Sp), two glutamine-rich domains (Q-rich), the btd-box (btd) and the three zinc fingers
(ZnF) of the Sp2 protein are indicated. Connecting lines with the corresponding murine Sp2 gene region indicate the derivation of N-terminal parts of
the Sp2 protein. The Sp-box and two glutamine-rich regions are encoded by exon 3. In the targeted Sp2 locus exon 3 and the IRES-lacZ-neo cassette
are floxed (black arrowheads). White arrowheads depict PCR primer locations (P1, P2 and P3). S, SacI sites. B) Southern blot analysis of transfected ES
cells for the Sp2wt allele (6.9 kb) and the targeted Sp2lzn allele (3.2 kb) using SacI-restricted genomic DNA and the 387 bp probe indicated in
Figure 2A. C) PCR analysis of E13.5 embryos for the Sp2lzn allele with the indicated primer combination (P1, P2 and P3).
doi:10.1371/journal.pone.0009587.g002
Sp2 Knockout Mice
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developmental defects displayed by Sp2lzn/lzn mutant embryos
indicate that Sp2 is required for normal embryonic development
at late embryonic stages.
Early Embryonic Lethality of Sp2null Mice
Northern blot and PCR analyses of tissues form Sp2lzn/lzn
embryos revealed aberrant mRNA expression from the targeted
Sp2 locus. As expression of small amounts of N-terminal
sequences of Sp2 could result in a hypomorphic phenotype we
generated Sp2null mice by crossing heterozygous Sp2wt/lzn
animals with CAG-Cre mice that express the Cre recombinase
under control of the cytomegalovirus immediate early enhancer-
chicken b-actin hybrid (CAG) promoter [18]. The resulting
heterozygous Sp2wt/ko mice were healthy and fertile, and were
intercrossed to generate Sp2null mice (Figure 5). Surprisingly, the
phenotype of Sp2null embryos differs markedly from that of
Sp2lzn/lzn embryos, strongly suggesting that the insertion of the
LacZ-neo fusion gene into the third intron did not disrupt Sp2
functions completely.
No Sp2null embryos were found alive beyond E10.5 (Table 2).
The few Sp2null embryos recovered at E12.5 to E13.5 were almost
completely reabsorbed. Embryos at E9.5 and earlier stages
displayed genotype distributions close to the expected Mendelian
ratios (Table 2).
Figure 3. Aberrant Sp2 mRNA expression in Sp2lzn/lznmice. A) Whole-mount lacZ staining of E12.5 embryos with the indicated genotypes. B)
Northern blot analysis of total RNA extracted from E18.5 embryos. RNA size markers are indicated on the left side. The 18S rRNA signal depicts the
loading control. The wild type Sp2 mRNA and the aberrant Sp2-IRES-LacZ-Neo mRNA are drawn schematically along with the Northern probe and the
primers Pex4 and Pex5 used for the PCR analysis shown in Figure 3C. The numbers 1 to 7 indicate the derivation of mRNA sequences from exons. C)
Absence of RNA derived from exons 4 and 5 in Sp2lzn/lzn mice. RT-PCR was performed with RNA from liver (L) and brain (B) of Sp2lzn/lzn, Sp2wt/lzn
and Sp2wt/wt embryos using the primers Pex4 and Pex5 indicated in Figure 3B. Amplification of cyclophilin (Cyc) mRNA sequences was used as a
positive control. D) Western blot analysis of Sp2 using extracts from primary mouse embryonic fibroblasts derived from E13.5 embryos with the
indicated genotypes. The asterisks denote cross-reacting proteins that serve as internal loading control.
doi:10.1371/journal.pone.0009587.g003
Table 1. Genotype distribution of Sp2wt/lzn intercrossings.
Sp2wt/lzn x Sp2wt/lzn Sp2wt/wt Sp2wt/lzn Sp2lzn/lzn
Born n= 91 (100%) 26 (28.6%) 64 (70.3%) 1* (1.1%)
E18.5 n = 54 (100%) 13 (24.1%) 31 (57.4%) 10 (18.5%)
E16.5 n = 13 (100%) 3 (23.1) 7 (53.8%) 3 (23.1)
E13.5 n = 72 (100%) 21 (29.2%) 36 (50.0%) 15 (20.8%)
E12.5 n = 106 (100%) 27 (25.5%) 50 (47.2%) 29 (27.4%)
E9.5 n = 51 (100%) 16 (31.4%) 22 (43.1%) 13 (25.5%)
P, postnatal day; E, day of embryonic development; n, number of mice/
embryos.
*died two weeks after birth.
doi:10.1371/journal.pone.0009587.t001
Sp2 Knockout Mice
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Figure 4. Impaired development of Sp2lzn/lzn embryos. A) Sp2lzn/lzn embryos at E18.5, E16.5 and E12.5 representing typical phenotypic
variants. Sp2lzn/lzn embryos at E12.5 have a normal body size but display hemorrhaging predominantly at the head. B) Embryo size distribution at
E12.5 and E18.5. The number of embryos analyzed is indicated at the bottom of the bars.
doi:10.1371/journal.pone.0009587.g004
Figure 5. Generation of Sp2null mice. (A) Mice carrying an Sp2null allele were obtained by crossing heterozygous Sp2wt/lzn mice with CAG-Cre
mice [18] thereby removing the selection marker (IRES-LacZ-Neo) and exon 3. Black arrowheads depict loxP sites, white arrowheads indicate PCR
primer locations. B) PCR analysis of the Sp2 wild type (wt) and the knockout (ko) allele using primers P1, P2 and P4 indicated in panel A. C)
Immunoblot analysis of Sp2 in extracts of primary mouse embryonic fibroblasts derived from E9.5 embryos with the indicated genotype. The asterisk
denotes a cross-reacting protein.
doi:10.1371/journal.pone.0009587.g005
Sp2 Knockout Mice
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Sp2null embryos developed until the nine somite stage but failed
to undergo body turning. At E9.5 Sp2null embryos were much
smaller than their littermates (Figure 6A). However, heartbeat and
superficial attachment of the allantois to the chorion were
observed. Generally, the appearance of E9.5 Sp2null embryos
was very similar to E8.5 wild type and heterozygous embryos
(Figure 6B) indicating a general developmental delay. This
conclusion is supported by serial longitudinal sections that revealed
that E9 Sp2 knockout embryos have an open cranial neural tube
(Figure 6C) typical for E8 wild type or Sp2 heterozygous embryos.
Growth and developmental retardation of Sp2-deficient em-
bryos were already visible at E7.5 exemplified by the expression
pattern of the mesodermal marker Brachyury. At this stage wild type
and heterozygous Sp2 embryos displayed intense Brachyury
expression. Expression of Brachyury in the smaller Sp2null
littermates, however, was very weak (Figure 6D) resembling
expression of Brachyury in the nascent primitive streak at the onset
of gastrulation of E6.5 embryos [19,20].
Generation of Conditional Sp2 Knockout Mice (Sp2cko/
cko Mice)
As inactivation of Sp2 is mid-gestational lethal we decided to
generate mice with floxed exon 3 lacking the IRES-LacZ-neo
cassette that would allow inactivating Sp2 in a stage-specific
manner as well as in cell lines derived from these mice. Generation
of such a conditional Sp2 knockout allele (Sp2cko allele) could be
accomplished by selective removal of the IRES-lacZ-neo cassette
upon partial Cre-loxP recombination (Figure 7). Injection of
fertilized eggs with different concentrations of Cre RNA [21]
resulted either in complete excision of exon 3 and the IRES-lacZ-
neo cassette or excision of exon 3, but never in excision of only the
Table 2. Genotype distribution of Sp2wt/ko intercrossings.
Sp2wt/ko x Sp2wt/ko Sp2wt/wt Sp2wt/ko Sp2null
P10 n = 81 (100%) 34 (42%) 47 (58%) 0 (0%)
E17.5 n = 7 (100%) 3 (42.9%) 4 (57.1%) 0 (0%)
E13.5 n = 8 (100%) 0 (0.0%) 8 (88.9%) 1* (11.1%)
E12.5 n = 23 (100%) 7 (26.9%) 16 (61.5%) 3* (11.5%)
E10.5 n = 39 (100%) 18 (46.2%) 20 (51.3%) 1 (2.6%)
E9.5 n = 303 (100%) 69 (22.8%) 166 (54.8%) 68+ (22.4%)
E8.5 n = 34 (100%) 10 (29.4%) 16 (47.1%) 7 (20.6%)
E7.5 n = 9 (100%) 1 (11.1%) 6 (66.7%) 2 (22.2%)
P, postnatal day; E, day of embryonic development; n, number of mice/
embryos.
*embryos were dead and reabsorbed.
+7 out of 68 embryos were reabsorbed.
doi:10.1371/journal.pone.0009587.t002
Figure 6. Phenotype of Sp2null embryos. A) An Sp2null embryo at E9.5 in comparison to wild type (Sp2wt) and heterozygous (Sp2+/2)
littermates. B) An Sp2null embryo at E9.5 in direct comparison to an E8.5 wild type embryo (Sp2wt). C) Serial longitudinal sections of heterozygous Sp2
(Sp2+/2) and Sp2null embryos from day E9.0. Sp2null embryos are smaller, have not turned and have an open cranial neural tube (Nt). Ne, neural
epithelium. D) Whole-mount in situ hybridization on E7.5 embryos using the mesodermal marker Brachyury as a probe.
doi:10.1371/journal.pone.0009587.g006
Sp2 Knockout Mice
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IRES-lacZ-neo cassette. Therefore, we employed an in vivo
approach.
MeuCre40 (mosaic-early embryonic-ubiquitous Cre transgene), a
transgenic mouse line that has been shown to generate partial
mosaic Cre-loxP recombination patterns in the early embryo [22],
were crossed with heterozygous Sp2wt/lzn mice. This resulted in
mosaicism for recombination events at the Sp2lzn locus that was
transmitted through the germline. After back crossing mosaic
animals to wild type mice we found a single female, out of 130
progeny analysed, that carried an allele with the desired floxed
exon 3 but lacking the IRES-lacZ-neo cassette (Sp2wt/cko)
(Figure 7B), the Sp2null allele and Cre recombinase. Crossing of
the single Sp2wt/cko female with wild type mice resulted also in
male Sp2wt/cko animals.
Homozygous Sp2cko/cko mice in which both Sp2 alleles are
floxed, were obtained by intercrossing of Sp2wt/cko mice.
Consistent with wild type Sp2 protein expression from the floxed
Sp2 locus (Figure 7C), Sp2cko/cko mice are phenotypically
indistinguishable from wild type animals.
Sp2 Is Essential for Proliferation of Mouse Embryonic
Fibroblasts
Mouse embryonic fibroblasts (MEFs) obtained from E9.5
Sp2null embryos became flat-shaped and did not divide, whereas
wild type and heterozygous MEFs derived from siblings grew
normally. The lack of proliferation of MEFs obtained from E9.5
Sp2null embryos could reflect the developmental retardation of
these embryos or could be due to the lack of Sp2. To explore
directly the potential role of Sp2 in cellular proliferation of MEFs
we isolated MEFs carrying floxed Sp2 alleles (Sp2cko/cko) from
E13.5 embryos. Sp2cko/ckoMEFs and corresponding wild type and
heterozygous MEFs (Sp2wt/cko) were immortalized by serial
passages of primary MEFs until they pass their growth-crisis
stage. Infection of Sp2cko/cko MEFs with a retrovirus expressing
Cre recombinase resulted in a time-dependent deletion of the
floxed Sp2 alleles and complete loss of the Sp2 protein at seven
days post-infection (Figure 8).
Consistent with previous reports [23,24] continuous Cre
expression in wild type cells slightly decreased growth (Figure 9).
However, Cre-mediated ablation of Sp2 in Sp2cko/cko MEFs
resulted in strongly reduced proliferation relative to control
retrovirus-infected cells (Figure 9). This finding together with the
observation that MEFs derived from Sp2null embryos do not
proliferate suggest a role of Sp2 in the control of cellular
proliferation.
To further substantiate the conclusion that Sp2 is essential for
proliferation of MEFs, we performed rescue experiments
(Figure 10). First we infected Sp2cko/cko MEFs with a retroviral
expression vector for Sp2 (pBABE-vSp2-puro), using infection with
the corresponding empty vector (pBABE-puro) as a control. The
resulting Sp2cko/cko-vSp2 MEFs expressed Sp2 ectopically in
addition to endogenous Sp2. Cre-mediated ablation of endoge-
nous Sp2 in Sp2cko/cko-pBABE-puro MEFs inhibited cell growth
(compare -Cre and +Cre growth curves in Figure 10A). Retroviral
Cre-infection of Sp2cko/cko-vSp2 led to a complete depletion of the
floxed Sp2 alleles as well (Figure 10B). However, expression of
ectopic Sp2 was unchanged (Figure 10C), and proliferation of
these MEFs was affected much less severe (compare +Cre and
+Cre+vSp2 growth curves in Figure 10A). These findings reinforce
the conclusion that Sp2 plays an essential role in cell proliferation.
Discussion
Sp2 was originally identified by virtue of the similarity of its zinc
finger region with the DNA-binding domain of Sp1 [15]. It is
Figure 7. Generation of conditional Sp2 mice (Sp2cko/cko mice). A) Crossing of heterozygous Sp2wt/lzn mice with MeuCre40 mice resulted in
generation of an Sp2cko allele in which the lacZ-Neo fusion gene is absent. B) PCR analysis of the Sp2 wild type (wt), Sp2-IRES-lacZ-Neo (lzn) and
Sp2cko (cko) alleles with the indicated primers. C) Western blot analysis of Sp2 in extracts of Sp2cko/cko, Sp2cko/wt and Sp2wt/wt MEFs.
doi:10.1371/journal.pone.0009587.g007
Sp2 Knockout Mice
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expressed in many different human and mouse cell lines [16]
suggesting wide-spread expression in vivo. Our Sp2 expression
analysis in mouse embryos supports this notion. Mouse Sp2
mRNA is detectable in embryonic stem cells and in all tissues
during different stages of mouse embryogenesis, with exception of
the heart. In Western blots, the mouse Sp2 protein appears as a
double band. Whether this is due to posttranslational modifica-
tions or reflects splice variants is unknown at this stage.
Insertion of the IRES-lacZ-Neo cassette into the third intron of
the Sp2 gene resulted in aberrant expression of an Sp2-lacZ-neo
fusion RNA in Sp2lzn/lzn mice. Although no Sp2 protein,
neither full-length nor a C-terminal truncated fragment was
detectable, it is very likely that the glutamine-rich N-terminal
part of Sp2 is expressed at a very low level. This would explain
why the Sp2lzn/lzn embryos display a markedly less severe
phenotype when compared to Sp2null embryos. Sp2lzn/lzn
embryos alive are found beyond E12.5 whereas disruption of
the Sp2 gene in Sp2null embryos causes severe developmental
retardation and embryonic lethality before E9.5. The different
phenotypes of Sp2lzn/lzn and Sp2null mice indicates that the
glutamine-rich N-terminal part of Sp2 has a function indepen-
dent of the C-terminal zinc finger domain that is believed to be
responsible for DNA-binding [16].
No particular cell lineage or developmental process appears to
be affected in Sp2null embryos. Rather, Sp2-deficiency causes a
general cellular defect that precludes normal progression of
development resulting in early embryonic lethality. This conclu-
sion is consistent with the observation that MEFs derived from
E9.5 Sp2null embryos did not grow in culture. Moreover, Sp2lzn/
lzn MEFs derived from E13.5 embryos stopped growing in culture
and repeatedly died after the first passage whereas MEFs from
wild type and Sp2wt/lzn littermates grew normally. Finally, Cre-
mediated ablation of Sp2 in Sp2cko/cko MEFs severely impaired
proliferation that could be rescued by ectopic expression of
exogenous Sp2. Altogether, these findings strongly suggest that
Sp2 is essential for the autonomous growth of MEFs in culture.
Further analyses will be necessary to unravel the cellular processes
that are responsible for the growth arrest of Sp2-depleted MEFs
and to identify key target genes of Sp2. Furthermore, the mice
carrying floxed Sp2 alleles described here will allow for the analysis
of the role of Sp2 in distinct cell types and in adult animals.
In conclusion, we have shown that Sp2 is required for normal
progression of embryonic development, and that it is essential for
survival of mouse embryos after E9.5. Sp2-deficient MEFs fail to
grow in vitro, strongly indicating that the lack of Sp2 causes a cell-
autonomous proliferation defect in these cells. Our data further
strengthen the notion that, despite their structural similarities, Sp1,
Sp2, Sp3 and Sp4 have non-redundant important functions during
mouse development. Future research in our laboratories will be
aimed at understanding the molecular basis for these distinct
functions. Conditional knockout alleles, such as described here for
the Sp2 gene, are essential tools to perform these studies.
Materials and Methods
Ethics Statement
Research involving mice have been conducted according to the
German Animal Protection Law (Tierschutzgesetz). The applica-
tion for the experiments was reviewed and approved by the
responsible local authorities (Regierungspra¨sidium Giessen, refer-
ence number V 54 - 19 c 20/15 cMR20/27).
Whole-Mount b-Gal Staining and In Situ Hybridization
Whole-mount b-galactosidase staining of E13.5 embryos was
performed according to Tewari et al. [25]. Whole-mount RNA in
situ hybridization was performed essentially as described [26] using
BM purple (Roche) as color substrate. For Sp2 mRNA detection,
we used a 903 bp digoxygenin-labeled fragment of exon 3
(nucleotides 183 to 1085 of mouse Sp2 cDNA) cloned in pcDNA3.
Appropriate plasmids to generate probes for Brachyury (T) and
Nkx2-5 were obtained from Martin Eilers and Thomas Braun,
respectively. The GATA4 probe is described in [9].
Generation of Sp2-Specific Antibodies and Immunoblot
A polyclonal antiserum against mouse Sp2 was generated by
immunization of New Zealand White rabbits with recombinant
full-length mouse Sp2 protein expressed in E. coli according to
standard procedures. The antiserum was subsequently affinity-
Figure 8. Depletion of Sp2 in Sp2cko/ckoMEFs upon retroviral Cre-infection. A) Schematic presentation of the Sp2cko allele and the Sp2null
allele obtained after retroviral Cre infection along with the positions of the primers used for genotyping. B) PCR analysis of Cre-infected Sp2cko/cko
MEFs at various time points post-infection as indicated. C) Western blot analysis of Sp2 in Cre-infected Sp2cko/cko and Sp2wt/wt MEFs at various time
points post-infection as indicated. The asterisk indicates a cross-reacting protein. To control for loading, the same blot was re-stained for Sp1.
doi:10.1371/journal.pone.0009587.g008
Sp2 Knockout Mice
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purified using immobilized recombinant Sp2. For immunoblots,
whole cell extracts from MEFs were separated through 6% SDS-
polyacrylamide gels and blotted to PVDF membranes. Primary
antibodies were visualized with the Amersham ECL kit.
Generation of Sp2lzn Mutant Mice
A cosmid clone containing exons 2 and 3 as well as flanking
intron sequences of the murine Sp2 gene was isolated from a
mouse 129/ola library at the German Science Centre for
Genome Research (RZPD). A targeting vector was designed to
flank exon 3 of the Sp2 gene and the selection marker with loxP
sites as follows. As starting vector, we used the pPNT plasmid
containing the pgk-driven neomycin resistance gene (pgk-neo) and
the herpes simplex thymidine kinase (hsv-tk) gene [27]. LoxP sites
flanking the pgk-neo cassette were inserted as synthetic XbaI-SalI-
LoxP-KpnI and NotI-XhoI-LoxP-SalI-[XhoI] oligonucleotides. A
1.8 kb fragment of intron 3 obtained by PCR was cloned into
the EcoRI site located between pgk-neo and hsv-tk. A fragment
containing exon 3 and flanking intron sequences was cloned as a
1.6 kb NotI-XhoI PCR fragment upstream of the floxed pgk-neo
cassette. A third loxP site was then inserted as NotI-BamHI-LoxP-
[NotI] oligonucleotide. Subsequently, a 3.2 kb Sp2 genomic
fragment containing exon 2 and flanking intron sequences was
inserted as NotI-BamHI PCR fragment. Finally, we replaced pgk-
neo by an SA-IRES-lacZ-neo-SVpA cassette obtained as a 7.4 kb SalI
fragment from pGT1.8Iresbgeo [28]. More detailed information
concerning the generation of the targeting vector will be provided
upon request. We verified all of the constructs by restriction
analysis and sequencing. The functionality of the loxP sites in the
final targeting vector was analyzed by appropriate restriction
digests after transformation into the Cre-expressing E. coli strain
294-Cre [29].
Figure 9. Sp2 is required for proliferation of MEFs. A) MEFs with the indicated genotypes were infected with a Cre-expressing (+ Cre) or an
empty control (- Cre) retrovirus, selected with puromycin for seven days and subsequently replated for determination of growth curves. The two
growth curves were performed with two different Sp2cko/cko lines. Results are presented as fold increase in cell number relative to time 0. The insert
in the upper panel shows a crystal violet staining of Sp2cko/ckoMEFs infected with an empty retrovirus (- Cre) or a Cre-expressing retrovirus (+ Cre). B)
PCR analyses of genomic DNA from Sp2wt/wt, Sp2wt/cko and Sp2cko/cko MEFs at day 0 of the growth curve determinations using the primer
combination P1, P2, P4. C) Immunoblot analysis of Sp2 with MEF extracts of the indicated genotype.
doi:10.1371/journal.pone.0009587.g009
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The targeting construct was introduced into C57BL/66129/
Ola F1 hybrid ES cells by electroporation and G418 resistant
clones were screened for homologous recombination by
Southern blotting using a 387 bp fragment overlapping intron
3 and exon 4 (Figure 2A). ES cells with a targeted Sp2 allele
were injected into blastocysts. Blastocysts were transferred to
pseudopregnant females and chimeric offspring were identified
by PCR. Chimeric mice were crossed to heterozygosity resulting
in Sp2wt/lzn mice.
Generation of Sp2null Mutant Mice
To generate an Sp2null allele, heterozygous Sp2wt/lzn mice were
mated with CAG-Cre mice [18]. The resulting heterozygous Sp2wt/
ko mice were intercrossed to generate Sp2null mice.
Generation of Conditional Sp2cko/cko Mice
Mosaic, early embryonic, ubiquitous Cre mice (MeuCre40)
[22] were crossed with Sp2wt/lzn mice to remove the LacZ-Neo
selection cassette from the Sp2 tri-loxP-allele. The F1 generation
was screened for the presence of the Cre gene and partial
recombination of the tri-loxP allele. Mice with partial and
mosaic patterns, eg positive for Cre and the floxed exon 3
(primers P6–P7), were then mated with C57Bl/6 mice for
segregation of the Cre-recombined alleles from MeuCre40 in the
F2 generation.
Genotyping Embryos and MEFs by PCR
The following primers and amplicons were used for genotyping
(see Figures 2, 5, 7 and 8 for orientation):
Primers:
P1: 59-CCCTCTCAGAACTTTCAGATC-39
P2: 59-CTTAGGAGGGATCTAGACTAG-39
P3: 59- CATCGCCTTCTATCGCCTTCTTGA-39
P4: 59- ACCGAGAGCAAGTTCATGTC-39
P5: 59- GCTATTGCTCTTGTCTTTAGC-39
P6: 59-TATCCCTGCGGATCCATAACT-39
P7: 59-GGATACTTGCATTTGATCGGC-39
vSp2: 59-TCAGCCCACTGATAGTCAGG-39
Cre 39: 59-CGATGCAACGAGTGATGAGGTTC-39
Cre 59: 59-GCACGTTCACCGGCATCAAC-39
Pex4: 59-ATTCAGCTGCCATTCTCCGA-39
Pex5: 59-AGCCCACTGATAGTCAGGTT-39
Amplicons:
Sp2 wild type allele: P1–P2: 760 bp; P1–P5: 457 bp
Lzn allele: P2–P3: 950 bp
Sp2null allele: P2–P4: 550 bp
Sp2cko allele: P1–P5: 487 bp
Lzn and Sp2cko alleles: P6–P7: 620 bp
pBABE-vSp2-puro: P1-vSp2: 421 bp
Sp2 cDNA: Pex4-Pex5: 229 bp
Northern Blot Analysis
Northern blot analysis was performed according to standard
protocols with 20 mg of total RNA extracted from E18.5 embryos
using a 32P-labeled 1.4 kb Sp2 cDNA probe encompassing exons 2
to 5 (Figure 3B).
Plasmids and Retroviral Infections
The pBABE-Cre-puro plasmid was previously described [30].
The retroviral pWLZ-Cre-neo plasmid was generated by cloning
the Cre recombinase from pBABE-Cre-puro as a [XhoI]-EcoRI
fragment into the [BamHI]-EcoRI-restricted pWLZ vector. The
retroviral expression plasmid for Sp2 (pBABE-Sp2-puro) was
obtained by cloning the full-length Sp2 cDNA into the BamHI
site of pBABE-puro.
High-titre viruses were produced by transient transfection of
retroviral constructs into the Phoenix-Eco packaging cell line using
FuGENE HD transfection reagent (Roche) according to standard
procedures. Retrovirally infected MEFs were selected with
appropriate antibiotics using the following concentrations: 2 mg/
mL of puromycin and 1 mg/mL of G418.
Determination of Growth Curves
MEFs were isolated from E9.5 and E13.5 embryos using
standard methods. MEFs were immortalized by serial passages of
primary MEFs. After retroviral infection MEFs were selected with
appropriate antibiotics for seven days. Subsequently, 2.56104 cells
were plated on 6-cm dishes and duplicates were counted after 2, 4
and 6 days.
Histology
Embryos were dissected and a tail snip or the yolk sac was
removed for genotyping. Embryos were fixed in Carnoy’s
solution (60% ethanol, 30% chloroform, 10% acetic acid) at
4uC overnight and embedded in paraffin according to standard
procedures. Sections (8 mm) were stained with hematoxylin and
eosin.
Figure 10. Partial rescue of proliferation by expression of
exogenous Sp2. A) Sp2cko/cko MEFs expressing exogenous Sp2
(vSp2) were infected with an empty control (- Cre) or a Cre-
expressing retrovirus (+ Cre), selected for seven days with puromycin
and subsequently replated for determination of the proliferation
rates. Results are presented as fold increase in cell number relative
to time 0. B) PCR analysis of Sp2cko/cko MEFs containing a retroviral
expression vector for Sp2 (vSp2). The primer combination P1, P2, P4,
vSp2 was used for amplification of the Sp2cko allele (P1–P2, 790 bp),
the Sp2ko allele (P2–P4, 550 bp) and the Sp2 cDNA (P1-vSp2,
421 bp). C) Western blot analysis of Sp2 in control and Cre-infected
Sp2cko/cko and Sp2cko/cko-vSp2 MEFs. The asterisk indicates a cross-
reacting band. To control for loading, the same blot was re-stained
for Sp1.
doi:10.1371/journal.pone.0009587.g010
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